PKM2 Promotes Lymphatic Metastasis of Hypopharyngeal Carcinoma Via Regulating Epithelial-mesenchymal Transition: an Experimental Research

Overview

Journal Diagn Pathol

Publisher Biomed Central

Specialty Pathology

Date 2024 Mar 2

PMID 38431604

Authors

Xin Zhou

Yanshi Li

Min Pan

Tao Lu

Chuan Liu

Zhihai Wang

Fengxiang Tang

Guohua Hu

Affiliations

Soon will be listed here.

Abstract

Background: Patients with hypopharyngeal carcinoma (HPC) have a poor prognosis mainly because of lymphatic metastasis. This research aimed to determine the PKM2 role in lymphatic metastasis in HPC and the underlying molecular mechanism contributing to this phenomenon.

Methods: PKM2 in HPC was studied for its expression and its likelihood of overall survival using TCGA dataset. Western blotting, qRT-PCR, and IHC were employed to confirm PKM2 expression. Methods including gain- and loss-of-function were used to examine the PKM2 role in HPC metastasis in vitro and in vivo. In vitro and in vivo studies also confirmed lymphatic metastasis's mechanism.

Results: Prominent PKM2 overexpression was seen in patients with lymphatic metastasis of HPC, and there was an inherent relationship between a high PKM2 level and poor prognosis. In vitro research showed that knocking down PKM2 decreased tumor cell invasion, migration, and proliferation while promoting apoptosis and inhibiting epithelial-mesenchymal transition, but overexpressing PKM2 had the reverse effect. Animal studies suggested that PKM2 may facilitate tumor development and lymphatic metastasis.

Conclusions: Our findings suggest that PKM2 may be a tumor's promoter gene of lymphatic metastasis, which may promote lymphatic metastasis of HPC by regulating epithelial-mesenchymal transition. PKM2 may be a biomarker of metastatic potential, ultimately providing a basis for exploring new therapeutic targets.

References

Goossens S, Vandamme N, Van Vlierberghe P, Berx G . EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET. Biochim Biophys Acta Rev Cancer. 2017; 1868(2):584-591. DOI: 10.1016/j.bbcan.2017.06.006. View

Yu D, Pan M, Li Y, Lu T, Wang Z, Liu C . RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. J Exp Clin Cancer Res. 2022; 41(1):6. PMC: 8722037. DOI: 10.1186/s13046-021-02212-1. View

Guo W, Zhang Z, Li G, Lai X, Gu R, Xu W . Pyruvate Kinase M2 Promotes Prostate Cancer Metastasis Through Regulating ERK1/2-COX-2 Signaling. Front Oncol. 2020; 10:544288. PMC: 7550821. DOI: 10.3389/fonc.2020.544288. View

Hirshoren N, Danne J, Dixon B, Magarey M, Kleid S, Webb A . Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2017; 39(4):772-778. DOI: 10.1002/hed.24683. View

Eckel H, Bradley P . Treatment Options for Hypopharyngeal Cancer. Adv Otorhinolaryngol. 2019; 83:47-53. DOI: 10.1159/000492308. View

Spector J, SESSIONS D, Haughey B, Chao K, Simpson J, El Mofty S . Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope. 2001; 111(6):1079-87. DOI: 10.1097/00005537-200106000-00028. View

Xing Y, Zhang J, Lin H, Gold K, Sturgis E, Garden A . Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma. Cancer. 2015; 122(4):534-45. PMC: 4742373. DOI: 10.1002/cncr.29780. View

Barroso Ribeiro R, Ribeiro Breda E, Fernandes Monteiro E . Prognostic significance of nodal metastasis in advanced tumors of the larynx and hypopharynx. Acta Otorrinolaringol Esp. 2012; 63(4):292-8. DOI: 10.1016/j.otorri.2012.02.012. View

Talmadge J, Fidler I . AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010; 70(14):5649-69. PMC: 4037932. DOI: 10.1158/0008-5472.CAN-10-1040. View

10.

Gao X, Wang H, Yang J, Liu X, Liu Z . Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell. 2012; 45(5):598-609. PMC: 3299833. DOI: 10.1016/j.molcel.2012.01.001. View

11.

Lu T, Li Y, Pan M, Yu D, Wang Z, Liu C . TBC1D14 inhibits autophagy to suppress lymph node metastasis in head and neck squamous cell carcinoma by downregulating macrophage erythroblast attacher. Int J Biol Sci. 2022; 18(5):1795-1812. PMC: 8935227. DOI: 10.7150/ijbs.68992. View

12.

Karaman S, Detmar M . Mechanisms of lymphatic metastasis. J Clin Invest. 2014; 124(3):922-8. PMC: 3938272. DOI: 10.1172/JCI71606. View

13.

Li Y, Pan M, Lu T, Yu D, Liu C, Wang Z . RAF1 promotes lymphatic metastasis of hypopharyngeal carcinoma via regulating LAGE1: an experimental research. J Transl Med. 2022; 20(1):255. PMC: 9172115. DOI: 10.1186/s12967-022-03468-7. View

14.

Chen Y, Chan A, Le Q, Blanchard P, Sun Y, Ma J . Nasopharyngeal carcinoma. Lancet. 2019; 394(10192):64-80. DOI: 10.1016/S0140-6736(19)30956-0. View

15.

Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K . Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001; 22(2):153-83. DOI: 10.1210/edrv.22.2.0428. View

16.

Chow L . Head and Neck Cancer. N Engl J Med. 2020; 382(1):60-72. DOI: 10.1056/NEJMra1715715. View

17.

Pastushenko I, Blanpain C . EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2018; 29(3):212-226. DOI: 10.1016/j.tcb.2018.12.001. View

18.

Christofk H, Vander Heiden M, Harris M, Ramanathan A, Gerszten R, Wei R . The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008; 452(7184):230-3. DOI: 10.1038/nature06734. View

19.

Onder T, Gupta P, Mani S, Yang J, Lander E, Weinberg R . Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008; 68(10):3645-54. DOI: 10.1158/0008-5472.CAN-07-2938. View

20.

Roberts T, Colevas A, Hara W, Holsinger F, Oakley-Girvan I, Divi V . Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. Cancer. 2016; 122(9):1388-97. DOI: 10.1002/cncr.29932. View